AI Article Synopsis
- A retrospective study was conducted at Izmir Tepecik Training and Research Hospital to assess the frequency of acute kidney injury (AKI) in critically ill COVID-19 patients from January 2020 to December 2021.
- Out of 177 patients, 49.7% experienced AKI, which typically developed around 7.63 days after hospitalization, with significant rates of progression in a subset of patients.
- The study found that AKI patients had much higher mortality rates in both the ICU (86.4%) and hospital settings (92%), emphasizing the importance of factors like age, SOFA score, and nephrotoxic agents in AKI risk during COVID-19 illness.
Article Abstract
This retrospective study was conducted at the Izmir Tepecik Training and Research Hospital from January 2020 to December 2021. It aimed to determine acute kidney injury (AKI) frequency and associated factors in critically ill COVID-19 patients. Out of 177 patients, 49.7% developed AKI, with an average onset of 7.63 days. AKI stages varied, and progression occurred in 27 patients within 48 hours. ICU and hospital mortality rates were significantly higher in AKI patients (86.4% and 92%, respectively) compared to non-AKI patients (19.1% and 22.5%). The study highlights age, sequential organ failure assessment (SOFA) score, and nephrotoxic agent presence as significant factors influencing AKI development in COVID-19 patients. Key Words: Critical care unit, COVID-19, Acute kidney failure.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.29271/jcpsp.2024.08.993 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!